{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:14:25Z","timestamp":1787238865720,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T00:00:00Z","timestamp":1658102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Reproductive Immunology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jri.2022.103662","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T11:15:40Z","timestamp":1657365340000},"page":"103662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Diagnosis and management of idiopathic recurrent pregnancy loss (RPL): Current immune testing and immunomodulatory treatment practice in the United Kingdom"],"prefix":"10.1016","volume":"153","author":[{"given":"Danai","family":"Bagkou Dimakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Tamblyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Justin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arri","family":"Coomarasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jri.2022.103662_bib1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1097\/AOG.0000000000002899","article-title":"ACOG practice bulletin No. 200: early pregnancy loss","volume":"132","author":"ACOG","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jri.2022.103662_bib2","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"ASRM","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103662_bib3","first-page":"1","article-title":"Recurrent pregnancy loss care pathway for Northern Ireland","author":"Benson","year":"2021","journal-title":"Public Health Agency"},{"key":"10.1016\/j.jri.2022.103662_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1191\/09612033043lu1091oa","article-title":"Cytokines in recurrent miscarriage","volume":"13","author":"Carp","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.jri.2022.103662_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.07.005","article-title":"Immunotherapy for recurrent pregnancy loss","volume":"60","author":"Carp","year":"2019","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103662_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/00016349409023451","article-title":"Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage","volume":"73","author":"Christiansen","year":"1994","journal-title":"Acta Obstet. Et Gynecol. Scand."},{"key":"10.1016\/j.jri.2022.103662_bib7","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(21)00681-4","article-title":"Recurrent miscarriage: evidence to accelerate action","volume":"397","author":"Coomarasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2022.103662_bib8","first-page":"79","article-title":"Side-effects of intravenous immune globulins","volume":"97","author":"Duhem","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib9","article-title":"Recurrent pregnancy loss","author":"ESHRE","year":"2017","journal-title":"Eur. Soc. Hum. Reprod. Embryol."},{"key":"10.1016\/j.jri.2022.103662_bib10","doi-asserted-by":"crossref","unstructured":"ESHRE, Atik, R.B., Christiansen, O.B., Elson, J., Kolte, A.M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., Quenby, S., Vermeulen, N. & Goddijn, M. (2018) ESHRE guideline: recurrent pregnancy loss. Human Reproduction Open, 2018, hoy004.","DOI":"10.1093\/hropen\/hoy004"},{"key":"10.1016\/j.jri.2022.103662_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jog.13837","article-title":"New insights into the mechanisms underlying recurrent pregnancy loss","volume":"45","author":"Ewington","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.jri.2022.103662_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/humupd\/dmy025","article-title":"The psychological impact of early pregnancy loss","volume":"24","author":"Farren","year":"2018","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2022.103662_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-020-00236-z","article-title":"Single-cell profiling of the human decidual immune microenvironment in patients with recurrent pregnancy loss","volume":"7","author":"Guo","year":"2021","journal-title":"Cell Discov."},{"key":"10.1016\/j.jri.2022.103662_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2016.02.015","article-title":"Pregnancy loss: French clinical practice guidelines","volume":"201","author":"Huchon","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jri.2022.103662_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004734.pub4","article-title":"Aspirin and\/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia","author":"de Jong","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jri.2022.103662_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/01443615.2020.1803241","article-title":"Are we managing women with Recurrent Miscarriage appropriately? A snapshot survey of clinical practice within the United Kingdom","volume":"41","author":"Manning","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.jri.2022.103662_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10815-018-1300-8","article-title":"Detailed endometrial immune assessment of both normal and adverse reproductive outcome populations","volume":"36","author":"Marron","year":"2019","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.jri.2022.103662_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.fertnstert.2022.04.015","article-title":"Evidence for the effectiveness of immunologic therapies in women with subfertility and\/or undergoing assisted reproduction","volume":"117","author":"Melo","year":"2022","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103662_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-0897.2002.01048.x","article-title":"Distributions of endometrial NK cells, B cells, T cells, and Th2\/Tc2 cells fail to predict pregnancy outcome following recurrent abortion","volume":"47","author":"Michimata","year":"2002","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib20","unstructured":"Ministry of Health & Family Welfare Government of India (2017) STANDARD TREATMENT GUIDELINES: Management of Recurrent Spontaneous Abortion. 1\u201320."},{"key":"10.1016\/j.jri.2022.103662_bib21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nri886","article-title":"Natural killer cells and pregnancy","volume":"2","author":"Moffett-King","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/aji.12079","article-title":"The role of B cells in pregnancy: the good and the bad","volume":"69","author":"Muzzio","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib23","unstructured":"NICE. (2020c) Miscarriage: What are the causes and risk factors? [Online]. Available: \u3008https:\/\/cks.nice.org.uk\/topics\/miscarriage\/background-information\/causes-risk-factors\/\u3009 [Accessed]."},{"key":"10.1016\/j.jri.2022.103662_bib24","unstructured":"NICE. (2020a) Miscarriage [Online]. Available: \u3008https:\/\/cks.nice.org.uk\/topics\/miscarriage\/\u3009 [Accessed]."},{"key":"10.1016\/j.jri.2022.103662_bib25","unstructured":"NICE. (2020b) Miscarriage: Scenario: Managing recurrent miscarriage [Online]. Available: \u3008https:\/\/cks.nice.org.uk\/topics\/miscarriage\/management\/managing-recurrent-miscarriage\/\u3009 [Accessed]."},{"key":"10.1016\/j.jri.2022.103662_bib26","unstructured":"NICE. (2021) Antenatal care [Online]. Available: \u3008https:\/\/www.nice.org.uk\/guidance\/ng201\u3009 [Accessed]."},{"key":"10.1016\/j.jri.2022.103662_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jri.2010.05.006","article-title":"The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth","volume":"87","author":"Nielsen","year":"2010","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib28","first-page":"1","article-title":"Early pregnancy loss","author":"Queensland Clinical Guidelines","year":"2018","journal-title":"Matern. Neonatal Clin. Guidel."},{"key":"10.1016\/j.jri.2022.103662_bib29","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jri.2022.103662_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/cimm.1999.1532","article-title":"Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions","volume":"196","author":"Raghupathy","year":"1999","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib31","first-page":"1","article-title":"The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage","volume":"17","author":"RCOG","year":"2011","journal-title":"Green -Top. Guidel."},{"key":"10.1016\/j.jri.2022.103662_bib32","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1006\/bbrc.1998.8549","article-title":"Shifts in the TH1\/TH2 balance during human pregnancy correlate with apoptotic changes","volume":"245","author":"Reinhard","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jri.2022.103662_bib33","article-title":"Treatment efficacy for idiopathic recurrent pregnancy loss - a systematic review and meta-analyses","author":"Roepke","year":"2018","journal-title":"Acta Obstet. Et Gynecol. Scand."},{"key":"10.1016\/j.jri.2022.103662_bib34","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2016.10.031","article-title":"Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials","volume":"107","author":"Saccone","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103662_bib35","unstructured":"Sanders, D., Kasraie, J., Lewis, S., Stewart, J., Pericleous-Smith, A., Farquharson, R., Feeney, A., Cheshire, S., Scott, B., Regan, L. & Evans, D. (2019) The responsible use of treatment add-ons in fertility services: a consensus statement 1\u20137."},{"key":"10.1016\/j.jri.2022.103662_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0015-0282(03)00611-3","article-title":"Differences in number and activity of peripheral natural killer cells in primary versus secondary recurrent miscarriage","volume":"80","author":"Shakhar","year":"2003","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jri.2022.103662_bib37","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/humrep\/deh159","article-title":"No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage","volume":"19","author":"Shimada","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jri.2022.103662_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12955-018-0982-z","article-title":"Quality of life and psychological distress in women with recurrent miscarriage: a comparative study","volume":"16","author":"Tavoli","year":"2018","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.jri.2022.103662_bib39","unstructured":"The Miscarriage Association (2020) Recurrent miscarriage. 1\u201316."},{"key":"10.1016\/j.jri.2022.103662_bib40","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.3390\/ijms20215332","article-title":"Endometrial immune dysfunction in recurrent pregnancy loss","volume":"20","author":"Ticconi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jri.2022.103662_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/a-0586-4568","article-title":"Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015\/050)","volume":"78","author":"Toth","year":"2018","journal-title":"Geburtshilfe und Frauenheilkd."},{"key":"10.1016\/j.jri.2022.103662_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/humupd\/dmz048","article-title":"Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis","volume":"26","author":"van Dijk","year":"2020","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.jri.2022.103662_bib43","first-page":"00003","article-title":"Single-cell immune landscape of human recurrent miscarriage","volume":"S1672\u20130229","author":"Wang","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.jri.2022.103662_bib44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1472-6483(10)60410-5","article-title":"Reappraisal of peripheral NK cells in women with recurrent miscarriage","volume":"17","author":"Wang","year":"2008","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.jri.2022.103662_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jri.2009.12.003","article-title":"Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients","volume":"84","author":"Wang","year":"2010","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.jri.2022.103662_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0897.2012.01133.x","article-title":"Peripheral blood NK cell cytotoxicities are negatively correlated with CD8(+) T cells in fertile women but not in women with a history of recurrent pregnancy loss","volume":"68","author":"Yoo","year":"2012","journal-title":"Am. J. Reprod. Immunol."}],"container-title":["Journal of Reproductive Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037822001917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165037822001917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:30:01Z","timestamp":1759033801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165037822001917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":46,"alternative-id":["S0165037822001917"],"URL":"https:\/\/doi.org\/10.1016\/j.jri.2022.103662","relation":{},"ISSN":["0165-0378"],"issn-type":[{"value":"0165-0378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of idiopathic recurrent pregnancy loss (RPL): Current immune testing and immunomodulatory treatment practice in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"Journal of Reproductive Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jri.2022.103662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103662"}}